duvoglustat

DRUG2 trials

Sponsors

Amicus Therapeutics

Conditions

Pompe Disease

Phase 2

Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease

TerminatedNCT00688597

Amicus TherapeuticsPompe Disease

Start: 2008-12-08End: 2009-12-14Updated: 2025-09-11

Drug-drug Interaction Study

CompletedNCT01380743

Amicus TherapeuticsPompe Disease

Start: 2011-10-31End: 2013-01-04Updated: 2025-06-26